Advantage Alpha Capital Partners LP Arcturus Therapeutics Holdings Inc. Transaction History

Advantage Alpha Capital Partners LP

  • $419 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$24.35 - $44.39 $69,178 - $126,111
-2,841 Reduced 9.51%
27,040 $658,000
Q1 2024

May 13, 2024
SELL
$31.23 - $42.99 $644,680 - $887,442
-20,643 Reduced 40.86%
29,881 $1.01 Million
Q4 2023

Feb 13, 2024
BUY
$17.71 - $32.97 $894,780 - $1.67 Million
50,524 New
50,524 $1.59 Million

Others Institutions Holding ARCT

# of Institutions
179
Shares Held
25.6M
Call Options Held
195K
Put Options Held
133K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $450M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Advantage Alpha Capital Partners LP Portfolio

Follow Advantage Alpha Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email